tiprankstipranks
Trending News
More News >
Voyageur Pharmaceuticals Ltd. (VYYRF)
:VYYRF
US Market

Voyageur Pharmaceuticals (VYYRF) Income Statement

Compare
2 Followers

Voyageur Pharmaceuticals Income Statement

Last quarter (Q1 2025), Voyageur Pharmaceuticals's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q1, Voyageur Pharmaceuticals's net income was C$-817.56K. See Voyageur Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ -1.57KC$ -2.19KC$ -2.91KC$ -2.25KC$ -1.48K
Operating Expenses
C$ 1.70MC$ 1.22MC$ 1.75MC$ 2.05MC$ 1.00M
Depreciation and Amortization
C$ 1.57KC$ 2.19KC$ 2.91KC$ 2.25KC$ 1.48K
EBITDA
C$ -1.71MC$ -1.22MC$ -1.75MC$ -2.05MC$ -1.12M
Operating Income
C$ -1.70MC$ -1.22MC$ -1.75MC$ -2.05MC$ -848.94K
Other Income/Expenses
C$ -7.94KC$ -178.52KC$ -1.97KC$ -3.28KC$ -154.84K
Pretax Income
C$ -1.71MC$ -1.40MC$ -1.75MC$ -2.05MC$ -1.14M
Net Income
C$ -1.71MC$ -1.40MC$ -1.75MC$ -2.05MC$ -1.14M
Per Share Metrics
Basic EPS
C$ -0.01C$ -0.01C$ -0.02C$ -0.02C$ -0.02
Diluted EPS
C$ -0.01C$ -0.01C$ -0.02C$ -0.02C$ -0.02
Weighted Average Shares Outstanding
137.63M 130.51M 107.83M 94.68M 70.53M
Weighted Average Shares Outstanding (Diluted)
137.63M 130.50M 107.83M 94.68M 70.53M
Currency in CAD

Voyageur Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis